Details for New Drug Application (NDA): 208749
✉ Email this page to a colleague
The generic ingredient in LEVOTHYROXINE SODIUM is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
Summary for 208749
Tradename: | LEVOTHYROXINE SODIUM |
Applicant: | Maia Pharms Inc |
Ingredient: | levothyroxine sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 208749
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 208749 | ANDA | Sagent Pharmaceuticals | 25021-468 | 25021-468-10 | 1 VIAL in 1 CARTON (25021-468-10) / 5 mL in 1 VIAL |
LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 208749 | ANDA | Sagent Pharmaceuticals | 25021-469 | 25021-469-10 | 1 VIAL in 1 CARTON (25021-469-10) / 5 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 100MCG/VIAL | ||||
Approval Date: | Dec 21, 2018 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 200MCG/VIAL | ||||
Approval Date: | Dec 21, 2018 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 500MCG/VIAL | ||||
Approval Date: | Dec 21, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription